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SUMMARY
HADDOX, M. K., J. R. WOMBLE, D. F. LARSON, W. R. ROESKE, AND D. H. RUSSELL.
Isoproterenol stimulation of ornithine decarboxylase blocked by propranolol during
ontogeny of the murine heart. Mol. Pharmacol. 20:382-386 (1981).
Fluctuations in the activity of fetal mouse heart ornithine decarboxylase (ODC) are
positively correlated to growth rate. ODC activity was maximal (27 pmoles/min/mg of
protein) at 13 days of embryogenesis, the earliest time that hearts could be dissected.
Stimulation of fetal cardiac ODC activity was used as an index of cardiac responsiveness
to adrenergic stimulation. The ability of either maternally injected or fetally injected
isoproterenol to stimulate an increase in fetal heart ODC activity in embryos close to
term was concentration-dependent. The beta-adrenergic stimulant, 10 mg/kg maternally
or 2 mg/kg fetally, promoted a maximal response (300-400%). Maternal injections were
used routinely, therefore, for ease of experimentation. The development of the fetal heart
trophic response to beta-receptor agonists was examined after maternal injections of 2 or
10 mg/kg of isoproterenol from 13 to 21 days of gestation. Isoproterenol promoted an
increase in myocardial ODC activity at all times monitored during fetal development.
The highest drug-stimulated activity, 57 pmoles/min/mg of protein, occurred at 16-17
days of gestation. After this, the absolute specific enzyme activity achieved after isopro-
terenol declined, although the magnitude of the response remained at 2.5- to 3-fold above
control until birth. The stimulation was blocked by propranolol (10 mg/kg s.c.). The
maximal in vito coupling of the beta-receptor to murine ODC activity, apparent from
Day 13 of gestation, precedes the development of its in vitro coupling to the chronotropic
response, first apparent after 1 7 days.
INTRODUCTION
The appearance of beta-receptors in the fetal mouse
heart, as determined by radioactive ligand binding
methods (1, 2), precedes any demonstrable effect of cat-
echolamines on the cardiac chronotropic or inotropic
response (1-3). Adrenergic stimulation of developing
heart tissue has profound effects on cellular nucleic acid
and protein synthesis patterns (4, 5), and the catechol-
amines have been postulated to play a key regulatory
role in cardiac cell proliferation and differentiation (4, 5).
However, the time during embryogenesis at which adre-
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nergic stimulation can actually influence cardiac devel-
opment is unknown.
In the adult animal, catecholamines have a trophic
effect on the heart, promoting increases in tissue protein,
RNA, and polyamine biosynthesis (6-8). One of the ear-
liest biochemical changes detectable in the cardiac
trophic response after beta-receptor stimulation by ad-
ministration of isoproterenol or norepinephrine is an
increase in the activity of ODC4 (EC 4.1.1.17), the rate-
limiting enzyme in the polyamine biosynthetic pathway
(9-12). There is a strict parallelism, shown to exist in a
large variety of species and tissues, between the rates of
tissue RNA and protein synthesis and the measurable
cellular polyamine content (13-15). Because ofthis strin-
gent relationship and the rapid and large fluctuations
that occur in the enzyme after tissue stimulation as a
result of its short turnover time (i.e., 10-20 mm) (16), the
activity of ODC has been suggested as a sensitive marker
in assessing the presence or absence of a tissue response
to a pharmacological stimulus (17, 18).
4 The abbreviation used is: ODC, ornithine decarboxylase.
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in assessing the presence or absence of a tissue response
to a pharmacological or physiological stimulus (17, 18).
The present study was undertaken to determine the
time of beta-receptor coupling to cardiac biosynthesis
during embryonic development of the mouse heart. The
ODC activity in the fetal heart was used as an indicator
of the acquisition of cellular responsiveness to adrenergic
input.
METHODS
CD-i mice obtained from Charles River Breeding Lab-
oratories, Inc. (Wilmington, Mass.) were housed on a 12-
hr photoperiod. Gestational age of the fetuses was timed
from a 24-hr period of exposure of the female to 12 males.
Females with vaginal plugs at the end of the 24-hr period
were separately caged and the day of plug observation
was counted as Day 1. Drugs were administered by s.c.
injection of the mother except where placental transfer
was evaluated. In these placental transport studies, the
mother was anesthetized with ether, the fetuses were
exposed by laparotomy, and each fetus was injected in
the area of the hip. The abdominal incision was closed
with a continuous suture and the mother was allowed to
recover from the anesthetic. Controls treated with 0.9%
NaCl solution were subjected to sham laparotomy. At
the appropriate time following drug administration, fe-
tuses of both sexes were delivered by caesarean section
and killed by cervical dislocation. The hearts were rapidly
excised, blotted and weighed, frozen by immersion in
liquid nitrogen, and stored at -80#{176}.The frozen tissue (5-
10 mg) was homogenized with a Tissumizer (Tekmar
Company, Cincinnati, Ohio) at 4#{176}in 1 ml of 50 mi
NaHPO4-KHPO4, pH 7.2, containing 5 mri NaF, 0.1 mr*vi
EDTA, 2 mM dithiothreitol, and 0.06 mi pyridoxal phos-
phate. Homogenates were centrifuged at 10,000 x g for
5 mm and two 200-gil aliquots of the resulting supernatant
were assayed for ODC activity. Incubations were con-
ducted at 37#{176}for 60 mm. The reaction was initiated by
the addition of 0.2 iCi of L-[’4C]ornithine (50 mCi/
mmole) (Amersham/Searle Corporation, Des Plaines,
Ill.) and cold ornithine to a final concentration of 0.25
mM. Pyridoxal phosphate-independent release of ‘4CO2
was determined by incubating an equivalent amount of
tissue supernatant in the presence of 4-bromo-3-hy-
droxyl-benzyloxyamine dihydrogen phosphate, and the
amount of release was subtracted from the sample value.
The reaction was terminated by the addition of 0.6 ml of
1 M citric acid. The reaction was continued for another
15 mm and the ‘4CO2 evolved was trapped by 20 .tl of 2
N NaOH on a 3 MM filter paper (Whatman Inc., Clifton,
N. J.) suspended above the reaction mixture in a plastic
well (Kontes Company, Vineland, N. J.). The filter paper
was then placed in toluene-Omnifluor (New England
Nuclear Corporation, Boston, Mass.) and radioactivity
was determined in a liquid scintillation spectrometer.
Specific activity of the enzyme is expressed as picomoles
of ‘4CO2 liberated per minute per milligram of protein.
Protein content of tissue supernatants was determined
by the dye-binding method of Bradford (19). The rate of
heart growth is very rapid (e.g., 2- to 3-fold increase per
24 hr) during the time of embryogenesis under study, and
the gestational age was estimated over a 24-hr period.
Additionally, interindividual differences in cardiac devel-
opment have been noted to be fairly large, even in the
same litter (20). Variations from litter to litter in post-
natal studies of ODC sensitivity to drug stimulation have
been noted (21). Therefore, to normalize the data so that
ODC activity could be compared with the exact growth
status of the organs assayed, all of the data of protein
content per heart obtained during the study were plotted
versus the estimated age (Fig. 1). The gestational age for
each embryonic heart assayed was then determined from
the averaged curve based on the individual heart protein
content.
RESULTS
Figure 2 shows the results of an experiment in which
the developmental pattern of ODC in the basal (unstim-
ulated) heart was determined. At all stages of embryo-
genesis examined, there was a significant amount of
enzyme activity present in the fetal mouse heart. At 13
days of gestation, the earliest time that hearts could be
dissected, ODC activity was maximal (27 pmoles/min/
mg of protein) and then declined progressively through-
out the remainder of gestation. The change in the basal
activity of the enzyme paralleled the changing growth
rate of the heart, as determined by the increment in
organ protein content (Fig. 2).
The concentration of isoproterenol required to stimu-
late an increase in fetal heart ODC was determined in a










The protein content of the 10,000 x g supernatant from the homog-
enized fetal hearts was determined by the dye-binding method of
Bradford (19), normalized per heart, and plotted versus the estimated
day ofembryogenesis. Each datapoint represents the mean ± standard
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FIG. 3. Isoproterenol stiniulate.s a dose-dependent increase in ODC
actititv of the fetal mouse heart
Mothers were injected s.c. with the indicated dose of isoproterenol
or 0.9 NaCl solution (control) 4 hr prior to assay of the fetal heart
OI)C activity. Bars represent the mean ± standard deviation of the
measurements of four to six separate heart pools, except for the highest
dose, at which there was significant fetal death.
Fa;. 2. Changes in OD(’ (iCtilitv lfl the fetal mouse heart (lul-ing
eflhl)lyogeflesis
The activity of Ol)C (#{149})in mouse hearts obtained at the indicated
day of gestation was assayed as described under Methods. Each data
point represents the mean ± standard deviation of measurements of
three or four heart pools. The rate of growth of the heart (0) was
calculated as the percentage increment in heart protein during each 2-
day period as given in Fig. 1.
to term (average 0.23 mg of protein per heart, estimated
20 days of gestation). The mothers were injected with
varying amounts of the beta-adrenergic agonist (s.c. in
0.5 ml of 0.9% NaCl solution) and, 4 hr later (the time of
maximal response in adult animals) (9-12), ODC activity
of the fetal heart was determined. As shown in Fig. 3, 1
mg/kg, the lowest dose producing a consistent response,
promoted a 60% elevation in enzyme activity, whereas
maximal ODC levels (420% of control) were achieved
with 10 mg/kg of isoproterenol. The response to the drug
was biphasic, since higher concentrations were less effec-
tive. This decrease in efficacy could be the result of drug-
induced cytotoxicity, since, at concentrations of 100 mg/
kg or greater, fetal death frequently occurred.
To ensure that maternal injection was comparable to
fetal administration, i.m. injections of 2 mg/kg and 10
mg/kg were given to fetuses at 17 days of gestation. All
of those receiving 10 mg/kg died, but ODC activity was
stimulated in hearts of fetuses given 2 mg/kg (Table 1).
Stimulation after direct fetal injection did not differ from
that of injected mothers. These experiments were added
in proof of stimulation of fetal beta-receptors after ma-
ternal injection. Propranolol blocked the increase in ODC
activity in response to isoproterenol after either fetal or
maternal injection.
In order to study the maturation of the heart trophic
response to beta-receptor stimulation, the ability of ma-
ternal injections of isoproterenol to elevate fetal heart
ODC was examined throughout embryogenesis. As
shown in Fig. 4, the beta-agonist promoted an increase
in cardiac enzyme activity at all times assayed during
fetal development. Although the basal ODC activity de-
dined from 13 to 17 days of embryogenesis, administra-
tion of 10 mg/kg of isoproterenol elevated the enzyme
activity to levels higher than the peak basal levels de-
tectable at 13 days. The highest drug-stimulated activity
(57 pmoles/min/mg of protein) occurred at 16-17 days
of gestation. After this, the elevation of ODC activity
detectable in response to isoproterenol administration
declined, although the magnitude of the stimulation re-
mained at a level approximately 2.5- to 3-fold above
control until birth. Companion litters at all stages of
embryogenesis also were tested with 2 mg/kg of isopro-
terenol to evaluate for possible changing sensitivity to
adrenergic stimulation during maturation. A response
pattern similar to that at 10 mg/kg was obtained with
TABLE 1
Fetal heart ornithine decarboxylase activity after fetal or maternal
injection
Fetuses were injected i.m. in the hip art (2 mg/kg). The average
weight of fetuses at 17 days was 500 mg, so they received 5 j.tg/25 p1.
Mothers received 10 mg/kg of isoproterenol s.c. Propranolol (10 mg/kg
s.c. maternal or i.m. fetal) was given 10 mm prior to isoproterenol in




Isoproterenol 49.5 ± 6.3 (n = 8)
0.9% NaC1 solution 12.1 ± 2.5 (n = 6)
Isoproterenol + propranolol 6.2 ± 0.9 (n = 6)
Mother
Isoproterenol 54.0 ± 4.7 (n = 5)
0.9% NaCI solution 8.2 ± 0.9 (n = 5)
Isoproterenol + propranolol 5.8 ± 0.06 (n = 5)
0.2
mg Protein/Heart
-I3--I5--I7- - 9 - --------- 21
FIG. 4. Isoproterenol stimulation of ODC induction in the fetal
mouse heart at different times of gestation
Isoproterenol ( 10 mg/kg; 0) or 0.9w NaCI solution (control; #{149})was
administered i.p. to mothers at the indicated days of gestation. The
activity of OI)C in the fetal heart was measured 4 hr after administra-
tion of the drug.
the lower dose, although the extent of the ODC increase
was never as great as that promoted by the higher dose.
The trophic response of the fetal mouse heart to beta-
adrenergic stimulation is compared with the chronotropic
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FIG. 5. Changes in the trophic and chronotropic response of fetal
mouse hearts- to isoproterenol during embryogenesis
The percentage increase stimulated by isoproterenol above basal
ODC activity in the fetal heart at the indicated days of embryogenesis
was calculated from the data in Fig. 4. The data showing the change in
heart rate of the fetal mouse heart in response to a maximally stimu-
lating dose ( 10 .1 M) of isoproterenol are taken from Roeske et al. (22).
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response were conducted with fetal hearts obtained from
mice of the same colony. Therefore, for the in vitro
chronotropic studies, the timing of developmental events
was under conditions identical with those for the in vivo
trophic response studies. The heart rate response was
not statistically elevated over the basal rate at 13 days
after isoproterenol administration (10 M), even though
a 107% increase was observed. At 17 days, the chrono-
tropic response was 131% above basal at a time of ODC
stimulation to 300% of control. These data compare
favorably with those of Wildenthal (3), who demon-
strated a 1 10% increase in heart rate at 13 days with 10
M isoproterenol and a 108% increase at 13 days with 10’
M norepinephrine. The beta-receptor is coupled to the
trophic response as assessed by the marked increase in
cardiac ODC activity which was measurable from 13 days
of gestation through birth, with peak effects demonstra-
ble at 16-17 days of development. In contrast, there is a
minimal effect of beta-receptor stimulation on mouse
heart rate at 13 days of gestation (1-3). The chronotropic
response to isoproterenol of 130% of basal rate (3), ap-
parent after 17 days, increases progressively in magnitude
until birth.
DISCUSSION
Catecholamines produce marked increases in cardiac
macromolecular biosynthesis in both the adult and de-
veloping animal (4-12). However, the time at which the
heart becomes responsive to trophic stimulation by ad-
renergic agents is unknown. As discussed by Bartolome
et al. (11) and Slotkin (17), the developmental factors
governing heart responsiveness to adrenergic stimulation
include (a) establishment of sympathetic innervation, (b)
200 development of cardiac beta-receptors, and (c) acquisi-
tion of cellular competence to respond to receptor stim-
ulation. In the developing mouse heart, atrial innervation
is thought to be complete after 15-16 days of gestation
(3, 20) and the appearance of cardiac beta-receptors
175 precedes this, with 14% of the adult density level appar-
ent at 13 days (1). These early receptors are functionally
coupled to adenylate cyclase activation (2), but do not
mediate a marked heart rate response (1, 3). The present
ISO () study examined the ontogeny of beta-receptor coupling
 to the heart biosynthetic response.
The induction of ODC, the rate-limiting enzyme in
l polyamine biosynthesis, is a ubiquitous component of the
25 . growth response (reviewed in refs. 17 and 18). Changes
: in cellular polyamine content have been shown to parallel
rates of RNA and protein synthesis in both embryonic
systems and in hypertrophy or hyperplasia of adult tis-
too sues (reviewed ref. in 13 and 14), including cardiac hy-
/ pertrophy (23-26). Therefore, we used the sensitivity of
cardiac ODC to adrenergic input as an index of whether
the beta-receptors present in the fetal tissue were coupled
to the cardiac trophic response. The trophic responsive-
ness of the fetal heart was found to be functionally
coupled to the beta-receptor from 13 days of gestation
through birth. The peak responsiveness, in terms of the
magnitude of the increase in enzyme activity promoted,
occurred at 17 days. This could reflect either a more
efficient coupling of the adrenergic receptor to the
trophic process or changes in the intracellular compo-
nents regulating RNA and protein synthesis.
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The dose of maternally injected isoproterenol required
to promote a maximal increase in the fetal heart ODC
(10 mg/kg) is 50- to 100-fold greater than that which
promotes an increase in the adult heart (9-12). The fetus
has been reported to be less sensitive to sympathomi-
metic amines than the adult (27); however, the affinity
of the murine fetal cardiac beta-receptors for adrenergic
agonists has been shown to be identical with that of the
adult (1, 2). Therefore, this large difference in efficacy
more likely represents the inefficiency of placental trans-
port of the drug. Direct fetal injections of 2 mg/kg were
comparable to 10 mg/kg s.c. to the mother. The question
of whether there is any transport at all from the maternal
circulation to the fetus has been a subject of controversy
(28-30). However, studies conducted using radioactively
labeled catecholamines (29, 30), as opposed to those
depending on a fetal physiological response (28) to mea-
sure possible transport, have shown that the drug crosses
the placenta and accumulates in the fetal heart. The
ability of direct fetal injection to produce stimulation of
fetal heart ODC activity similar to that produced by
maternal injection, as well as the ability of propranolol
to block this increase after either procedure, substanti-
ates the occurrence of stimulation of fetal heart beta-
receptors after maternal injection.
The development of the cardiac trophic response to
beta-adrenergic stimulation appears to precede expres-
sion of the chronotropic response. This is in harmony
with the ability to detect beta-receptors during murine
heart development prior to the development of signifi-
cant responsiveness to beta-agonists as measured by a
detectable heart rate response (1). Although the compar-
ison of in vitro findings concerning the chronotropic
response with in vivo trophic stimulation is subject to
question, measurement of heart rate changes on freshly
isolated hearts under stable, controlled conditions avoids
the confusing influences of secondary changes in heart
rate produced by neural and humoral factors. This com-
parison is further substantiated by almost identical re-
sults on the chronotropic responses which were obtained
by this (1, 2) and another laboratory (3), even though the
timing of developmental studies might be different in
separate laboratories. Further studies are in progress to
assess whether the receptors coupled to the cardiac
trophic response have pharmacological properties differ-
ent from those coupled to the chronotrophic response.
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